Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Directorate Change

11 Feb 2019 07:00

RNS Number : 5635P
Athelney Trust PLC
11 February 2019
 

Athelney Trust plc

Legal Entity Identifier:

213800ON67TJC7F4DL05

Appointment of Directors

Athelney Trust plc is pleased to announce the appointment of Helen Sachdev as a Non-Executive Director of the Company, effective immediately. In addition, the Company announces that Frank Ashton, currently a Non-Executive Director of the Company, has also been appointed Executive Chairman of the Company with immediate effect.

Helen Sachdev

Helen Sachdev, aged 53, is currently Non-Executive Director and Audit Chair of Loughborough Building Society, and was Non-Executive Director of Communisis plc, the leading provider of personalised customer communication services, until its acquisition in December 2018. Helen is also currently a Director with the coaching consultancy, WOMBA.

Helen is a Fellow of the Chartered Institute of Management Accountants and has a BA (Hons) in Retail Marketing from Manchester Metropolitan University. Helen brings a wealth of experience as a non-executive director, underpinned by extensive blue chip executive experience having worked in senior positions at Barclays plc, Tesco and Sainsbury's, and she has a proven track record of operational expertise, corporate development and strategy implementation.

The current Board of the Company therefore comprises:

· Frank Ashton (Executive Chairman)

· David Lawman (Non-Executive Director)

· Helen Sachdev (Non-Executive Director)

All directors sit on both the Audit and Remuneration Committees, and Helen Sachdev will Chair the Audit Committee.

It is recognised that Frank Ashton's role as Executive Chairman is not compliant with the UK Corporate Governance Code. However after full consideration by the Board it is deemed appropriate at this critical time for the Company. As well as being a critical time in the financial reporting cycle the board is negotiating transition to the Company's future external Fund Management with Gresham House Asset Management. This was supported implicitly by voting at the EGM on 22 January 2019. A detailed explanation of the non-compliant position is available on the Company's website, as is the result of the EGM voting and 11 January 2019 statement on the EGM.

To the best of their knowledge, a majority of the Directors, namely Frank Ashton and Helen Sachdev, have no current or prior connection with any major shareholder of Athelney Trust plc.

Frank Ashton, Chairman of Athelney Trust plc, said: 

"I am delighted to welcome Helen Sachdev to the Athelney Trust Board, joining David Lawman and myself. 

"We now have a strong Board that I believe has the necessary experience and expertise to stabilise Athelney and move it forward to the next stage of its growth. I look forward to introducing each director to shareholders, and talking more about our plans for the Company's future, at the next scheduled meeting which is the Annual General Meeting on 3rd April 2019."

Listing Rule disclosures

Helen Sachdev was a Director of Communisis PLC until December 2018.

There are no further details or disclosures required under Listing Rule 9.6.13R in respect of Helen Sachdev.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABDGDDXBBBGCG
Date   Source Headline
3rd Jun 20267:22 amRNSNet Asset Value(s)
6th May 20267:35 amRNSNet Asset Value(s)
16th Apr 20268:50 amRNSAGM Statement
7th Apr 20267:00 amRNSNet Asset Value(s)
3rd Mar 20263:15 pmRNSAnnual Financial Report
3rd Mar 202612:09 pmRNSNet Asset Value(s)
3rd Feb 20268:27 amRNSNet Asset Value(s)
5th Jan 20269:53 amRNSNet Asset Value(s)
2nd Dec 202510:41 amRNSNet Asset Value(s)
4th Nov 202511:01 amRNSNet Asset Value(s)
10th Oct 20252:27 pmRNSAuditor change
9th Oct 20254:08 pmRNSNet Asset Value(s)
3rd Oct 20257:02 amRNSNet Asset Value(s)
2nd Sep 20259:09 amRNSNet Asset Value(s)
4th Aug 202510:48 amRNSNet Asset Value(s)
25th Jul 20257:00 amRNSHalf-year Report
3rd Jul 20257:00 amRNSNet Asset Value(s)
3rd Jun 202512:08 pmRNSNet Asset Value(s)
6th May 20258:59 amRNSNet Asset Value(s)
24th Apr 20257:11 amRNSResult of the AGM
2nd Apr 20259:38 amRNSNet Asset Value(s)
11th Mar 20254:15 pmRNSAnnual Financial Report
4th Mar 202512:03 pmRNSNet Asset Value(s)
5th Feb 20258:01 amRNSNet Asset Value(s)
6th Jan 202510:25 amRNSNet Asset Value(s)
3rd Dec 20248:21 amRNSNet Asset Value(s)
4th Nov 20247:53 amRNSNet Asset Value(s)
10th Oct 20248:13 amRNSAuditor Appointment
3rd Oct 20241:29 pmRNSNet Asset Value(s)
4th Sep 20249:46 amRNSNet Asset Value(s)
16th Aug 20242:21 pmRNSChange of Adviser
2nd Aug 20247:46 amRNSNet Asset Value(s)
24th Jul 20242:03 pmRNSHalf-year Report
2nd Jul 202411:59 amRNSNet Asset Value(s)
6th Jun 20247:00 amRNSNet Asset Value(s)
7th May 20249:54 amRNSNet Asset Value(s)
4th Apr 20249:21 amRNSNet Asset Value(s)
22nd Mar 20248:15 amRNSAGM Statement
5th Mar 20242:04 pmRNSNet Asset Value(s)
13th Feb 202411:58 amRNSDividend Declaration
5th Feb 202410:17 amRNSNet Asset Value(s)
3rd Jan 202411:13 amRNSNet Asset Value(s)
5th Dec 20232:45 pmRNSNet Asset Value(s)
6th Nov 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:29 amRNSAuditor appointment
10th Oct 202310:54 amRNSChange of Adviser
4th Oct 20232:58 pmRNSNet Asset Value(s)
4th Sep 202311:17 amRNSNet Asset Value(s)
2nd Aug 20239:06 amRNSNet Asset Value(s)
25th Jul 202311:37 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.